Inventor · disambiguated record
Somhairle Maccormick
Also filed as: MACCORMICK SOMHAIRLE
18 granted patents·7 pending applications·282 citations·filing 2009–2022
95Inventor score
Files withVERTEX PHARMA10KARUS THERAPEUTICS LTD6CHARRIER JEAN-DAMIEN4PHARMACYTICS B V2EVERITT SIMON1
Top patents by PatentIndex Score
25 records- 0198US9701674B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2014·Granted Jul 11, 2017·22 cites·61 claims
- 0298US9365557B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Jun 14, 2016·27 cites·54 claims
- 0398US8841308B2Pyrazin-2-amines useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2009·Granted Sep 23, 2014·54 cites·11 claims
- 0497US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 0595US9309250B2Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitorsSTORCK PIERRE-HENRI·Filed 2012·Granted Apr 12, 2016·22 cites·40 claims
- 0693US8822469B2Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinaseMACCORMICK SOMHAIRLE·Filed 2012·Granted Sep 2, 2014·22 cites·40 claims
- 0793US8623869B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jan 7, 2014·20 cites·42 claims
- 0891US10479784B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Nov 19, 2019·3 cites·10 claims
- 0990US9096602B2Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitorsEVERITT SIMON·Filed 2012·Granted Aug 4, 2015·20 cites·3 claims
- 1090US8877759B2Aminopyrazines as ATR kinase inhibitorsCHARRIER JEAN-DAMIEN·Filed 2012·Granted Nov 4, 2014·16 cites·34 claims
- 1187US10961232B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2017·Granted Mar 30, 2021·2 cites·24 claims
- 1284US10407435B2Diheteroaryl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Sep 10, 2019·6 cites·19 claims
- 1381US10150763B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 11, 2018·3 cites·16 claims
- 1480US9862685B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2014·Granted Jan 9, 2018·4 cites·12 claims
- 1579US9676765B2Histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2013·Granted Jun 13, 2017·4 cites·8 claims
- 1675US2023030414A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1767US10533003B2Polyheteroarl histone deacetylase inhibitors and their use in therapyKARUS THERAPEUTICS LTD·Filed 2015·Granted Jan 14, 2020·1 cites·7 claims
- 1863US2016311809A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 1963US2014288347A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2062US10870624B2Histone deacetylase inhibitorsKARUS THERAPEUTICS LTD·Filed 2017·Granted Dec 22, 2020·0 cites·5 claims
- 2154US2024299554A1Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl unitsPHARMACYTICS B V·Filed 2022·Application pending·0 cites
- 2252US2015376187A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2349US2014113005A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2449US2016009723A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2539US11633484B2Method for improving the oral bioavailability of a drugPHARMACYTICS B V·Filed 2018·Granted Apr 25, 2023·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →